Jay Gucky

Jay Gucky is an experienced professional in the biopharmaceutical industry, currently serving as the Head of Global Immunology Commercialization at Sobi - Swedish Orphan Biovitrum AB (publ) since September 2022. Prior to this role, Jay Gucky was with UCB from September 2010 to October 2022, where positions included Senior Director of Global Commercial and Global Marketing Director for both the Immuno Dermatology Portfolio and International Markets for Bimekizumab. Earlier career experiences include various marketing and leadership roles at Abbott Laboratories and Eli Lilly and Company. Jay Gucky holds a D.D.S. from the Indiana University School of Medicine and a BS in Marketing from Indiana University Bloomington.